| Postmenopausal hormone therapy: an Endocrine Society scientific statement RJ Santen, DC Allred, SP Ardoin, DF Archer, N Boyd, GD Braunstein, ... The Journal of Clinical Endocrinology & Metabolism 95 (7_supplement_1), s1-s66, 2010 | 935 | 2010 |
| The role of microparticles in inflammation and thrombosis SP Ardoin, JC Shanahan, DS Pisetsky Scandinavian journal of immunology 66 (2‐3), 159-165, 2007 | 267 | 2007 |
| Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus R Mina, E Von Scheven, SP Ardoin, BA Eberhard, M Punaro, N Ilowite, ... Arthritis care & research 64 (3), 375-383, 2012 | 208 | 2012 |
| Use of atorvastatin in systemic lupus erythematosus in children and adolescents LE Schanberg, C Sandborg, HX Barnhart, SP Ardoin, E Yow, GW Evans, ... Arthritis & Rheumatism 64 (1), 285-296, 2012 | 186 | 2012 |
| Update on nonsteriodal anti-inflammatory drugs SP Ardoin, JS Sundy Current opinion in rheumatology 18 (3), 221-226, 2006 | 152 | 2006 |
| Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima‐media thickness in the Atherosclerosis Prevention in Pediatric … LE Schanberg, C Sandborg, HX Barnhart, SP Ardoin, E Yow, GW Evans, ... Arthritis & Rheumatism 60 (5), 1496-1507, 2009 | 147 | 2009 |
| Developments in the scientific understanding of lupus SP Ardoin, DS Pisetsky Arthritis research & therapy 10, 1-8, 2008 | 142 | 2008 |
| Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up SP Ardoin, D Kredich, E Rabinovich, LE Schanberg, GJ Jaffe American journal of ophthalmology 144 (6), 844-849. e1, 2007 | 135 | 2007 |
| Assessment of transition readiness in adolescents and young adults with chronic health conditions PT Jensen, GV Paul, S LaCount, J Peng, CH Spencer, GC Higgins, ... Pediatric Rheumatology 15, 1-7, 2017 | 101 | 2017 |
| Despite high objective numeracy, lower numeric confidence relates to worse financial and medical outcomes E Peters, MK Tompkins, MAZ Knoll, SP Ardoin, B Shoots-Reinhard, ... Proceedings of the National Academy of Sciences 116 (39), 19386-19391, 2019 | 83 | 2019 |
| Development of a novel renal activity index of lupus nephritis in children and young adults HI Brunner, MR Bennett, K Abulaban, MS Klein‐Gitelman, KM O'Neil, ... Arthritis care & research 68 (7), 1003-1011, 2016 | 81 | 2016 |
| Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein SP Ardoin, LE Schanberg, CI Sandborg, HX Barnhart, GW Evans, E Yow, ... Annals of the rheumatic diseases 73 (3), 557-566, 2014 | 81 | 2014 |
| Quantitative evaluation of a pediatric rheumatology transition program PT Jensen, J Karnes, K Jones, A Lehman, R Rennebohm, GC Higgins, ... Pediatric Rheumatology 13, 1-6, 2015 | 80 | 2015 |
| The complement system and human autoimmune diseases SL Coss, D Zhou, GT Chua, RA Aziz, RP Hoffman, YL Wu, SP Ardoin, ... Journal of autoimmunity 137, 102979, 2023 | 76 | 2023 |
| Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders CB Cho, SA Stutes, ML Altrich, SP Ardoin, G Phillips, PU Ogbogu Annals of Allergy, Asthma & Immunology 110 (1), 29-33, 2013 | 73 | 2013 |
| Transitioning youth with rheumatic conditions: perspectives of pediatric rheumatology providers in the United States and Canada P Chira, T Ronis, S Ardoin, P White The Journal of rheumatology 41 (4), 768-779, 2014 | 72 | 2014 |
| The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation SP Ardoin, DS Pisetsky Modern Rheumatology 18 (4), 319-326, 2008 | 72 | 2008 |
| Management of dyslipidemia in children and adolescents with systemic lupus erythematosus SP Ardoin, C Sandborg, LE Schanberg Lupus 16 (8), 618-626, 2007 | 70 | 2007 |
| Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort SP Ardoin, LE Schanberg, C Sandborg, E Yow, HX Barnhart, ... Lupus 19 (11), 1315-1325, 2010 | 63 | 2010 |
| Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus NA Young, GR Valiente, JM Hampton, LC Wu, CJ Burd, WL Willis, ... Clinical immunology 176, 12-22, 2017 | 54 | 2017 |
